Status:
UNKNOWN
Effect of an Advanced Notification Letter on Screening Colonoscopy Participation
Lead Sponsor:
Maria Sklodowska-Curie National Research Institute of Oncology
Collaborating Sponsors:
Centre of Postgraduate Medical Education
European Union
Conditions:
Colorectal Cancer
Adenoma
Eligibility:
All Genders
55-64 years
Phase:
NA
Brief Summary
Participation in a primary screening colonoscopy programs remains low. Advanced notification letter has been shown to increase participation in colorectal cancer screening with fecal occult blood test...
Eligibility Criteria
Inclusion
- all individuals aged 55-64 years living in the counties covered with the organized CRC screening program and assigned to invitation to screening colonoscopy in the year 2014 are eligible for the study.
Exclusion
- message from neighbor/family/post office on death of screenee (not updated in Population Registry)
- resident abroad (not updated in Population Registry)
- return of unopened letter of invitation and/or reminder (address unknown)
- diagnosis of CRC before the date of draw (not updated in the National Cancer Registry)
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2015
Estimated Enrollment :
6800 Patients enrolled
Trial Details
Trial ID
NCT02188927
Start Date
August 1 2014
End Date
February 1 2015
Last Update
July 14 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
Warsaw, Mazovian, Poland